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Introduction

39!
Once discovered and developed, most Western medicines are manufactured and made 40! available via centralized and regulated industrial supply chains [Liu, 2011; World Health 41! Organization, 2011] . For example, in 1999 almost 93 percent of global pharmaceutical 42! production by value occurred in countries with a gross national product per capita above 43! $9,360, with the top five producing countries (USA, Japan, France, Germany, UK) 44! accounting for ~67 percent of production by value [World Health Organization, 2011] . 45! However, the majority of people who need medicines cannot reliably afford or even 46! access them [Seya et al., 2011] . 47!
48!
Yeast are naturally occurring microorganisms that live on every continent including 49! Antarctica [Carrasco et al., 2012] . Humans have adapted yeast to leaven bread and brew 50! wine or beer [Mortimer, 2000] . Fermentation with adapted yeast is widely practiced by 51! diverse peoples, from subsistence farmers in Northern Nigeria [Netting, 1964] to citizens 52! of modern industrialized nations who might otherwise favor specialization of labor and 53! centralized manufacturing [Enkerli, 2006] . 54!
55!
Following the development of recombinant DNA technology [Jackson et al., 1972] yeast 56! have been directly engineered to make various substances, from bulk and fine chemicals 57! to active pharmaceutical ingredients [Li & Borodina, 2014; Siddiqui et al., 2012] . In 58! cases where yeast is used to make a product that already exists, yeast-based fermentations 59! can displace existing supply chains. Such displacements can be disruptive. For example, 60! yeast-based biosynthesis enabling production of semi-synthetic artemisinin is expected to 61! ! 4! both lower the price and stabilize the supply of an essential antimalarial medicine 62! [Paddon & Keasling, 2014] . Because yeast use sugar as their primary carbon and energy 63! source, the agricultural input to a yeast-based manufacturing process can be decoupled 64! from the resulting product. Thus, a few crop plants (rice, corn, sugarcane, beets, 65! potatoes) can be optimized for intensive agricultural production of commodity feedstock 66! sugars while many different yeast strains are engineered to produce a diversity of 67! products. As a result, land use and employment are impacted. For example, yeast-based 68! biosynthesis of artemisinin is estimated to reduce agricultural land use and labor 69! requirements 35-fold and 1000-fold, respectively, relative to traditional sourcing via 70! cultivation of sweet wormwood [Jim Thomas, personal communication]. 71!
72!
Yeast have very recently been engineered to make medicinal opioids at low titers 73! [Galanie et al., 2015] . The existing supply chain for these essential and regulated 74! medicines is again plant-based, starting with the farming of opium poppies [Galanie et 75! al., 2015 and references therein] . In part due to widespread addiction and abuse of these 76! compounds, many have imagined or expressed public concern at the prospect of yeast-77! based biosynthesis of opioids by individuals via home-brew fermentation. For example, 78! Professor Voigt of MIT recently stated that "It is going to be possible to 'home-brew' 79! opiates in the near future" and that a dose could be obtained from "a glass of yeast culture 80! grown with sugar on a windowsill" [Begley, 2015] . Professor Oye of MIT argued that 81! access to yeast strains engineered to produce narcotics should be restricted to licensed 82! facilities, authorized researchers, and technicians [Oye et al., 2015] . 83! 84! ! 5! However, it is not entirely obvious that restricted access to or criminalization of 85! controlled substances leads to better public health outcomes [Greenwald, 2009] Figure 2 ]. After 120 h, 1 mL samples were removed, 111! centrifuged 10 min at full speed to precipitate yeast and particulates, and analyzed to 112! determine reticuline and thebaine concentrations by high performance liquid 113! chromatography-tandem mass spectrometry (HPLC-MS/MS) using multiple reaction 114! monitoring (MRM) according to our previously published method [Galanie et al., 2015] .
115!
The Safale S-04 positive fermentation control was also tested by tasting. 
